PK

Punam Kumari

Active Director Director DIN 07725058
DIN 07725058 First appointment Mar 2017 Primary industry Oil & Gas
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Mar 2017
Shareholding value •••• Premium profile

About Punam Kumari

Data last updated:

Punam Kumari is a Director at Vetbac Pharmaceuticals Private Limited (since 2017). The company operates in Oil & Gas. Vetbac Pharmaceuticals Private Limited reported revenue of ₹47.9 Lakh (FY 2024).

DIN 07725058
Primary Designation Director
Industry Oil & Gas
First Appointment 27 Mar 2017
Oldest Company Age 9 yrs
Largest company Vetbac Pharmaceuticals Private Limited · ₹47.9 Lakh (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director27 Mar 20172017₹47.9 Lakh (FY 2024)Active

Board colleagues of Punam Kumari

Directorship timeline

Open interactive timeline →
Vetbac Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Punam Kumari

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Punam Kumari

Punam Kumari currently holds 1 directorship: Vetbac Pharmaceuticals Private Limited (Director, since 27 Mar 2017, revenue ₹47.9 Lakh (FY 2024)).

Punam Kumari was first appointed on 27 Mar 2017 as Director at Vetbac Pharmaceuticals Private Limited.

The current boards of Punam Kumari's companies include Pratima Pandey (Vetbac Pharmaceuticals Private Limited), Rakesh Roshan (Vetbac Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available